Inactivation of TSE agents: safety of blood and blood-derived products

Brown, 1995, Can Creutzfeldt-Jakob disease be transmitted by transfusion?, Curr Opin Haematol, 2, 472, 10.1097/00062752-199502060-00012

Brown, 1999, Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans, Transfusion, 39, 1169, 10.1046/j.1537-2995.1999.39111169.x

Bruce, 2001, Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues, Lancet, 358, 208, 10.1016/S0140-6736(01)05411-3

Kimberlin, 1983, Disinfection studies with two strains of mouse-passaged scrapie agent, J Neurol Sci, 59, 335, 10.1016/0022-510X(83)90021-7

Operalski, 1995, Pooled plasma derivatives and Creutzfeldt-Jakob disease, Lancet, 346, 1224, 10.1016/S0140-6736(95)92925-8

Reichl, 2001, Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin, Vox Sanguinis, 83, 137, 10.1046/j.1423-0410.2002.00211.x

Taylor, 1999, Inactivation of prions by physical and chemical means, J Hosp Infection, 43, 569

Taylor, 2000, Inactivation of transmissible degenerative encephalopathy agents: a review, Vet J, 159, 10, 10.1053/tvjl.1999.0406

Taylor, 1994, Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie, Arch Virol, 139, 313, 10.1007/BF01310794

Taylor, 2000, Infectivity in the blood of mice with a BSE-derived agent, J Hosp Infection, 46, 78, 10.1053/jhin.2000.0790